Latest Headlines

Latest Headlines

Study: Brain scan can be used to distinguish between traumatic brain injury and PTSD

Traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) have virtually indistinguishable symptoms, yet each requires a different approach for effective treatment. Now, in what is thought to be the largest functional neuroimaging study to date, researchers have identified biological differences between TBI and PTSD by using single photon emission computed tomography to scan the brain.

Veterans say experimental, 'brain zapping' magnetic resonance therapy can treat PTSD

Veterans interviewed by the Washington Post hail experimental magnetic resonance therapy as a possible treatment for post-traumatic stress disorder. Families of autistic children made similar claims.

Tonix receives IND approval for sublingual formulation to treat PTSD

Tonix Pharmaceuticals announced June 10 that its investigational reformulation of cyclobenzaprine, TNX-102 SL, received IND clearance from the FDA for the treatment of post-traumatic stress disorder. The news comes about a month after the company said that TNX-102 SL's pivotal trial for the treatment of fibromyalgia completed enrollment.

NYU investigative team on the trail of PTSD biomarkers

A group of investigators at New York University's medical school has launched an ambitious effort to define a group of biomarkers that could be used to quickly and easily diagnose complex cases of post-traumatic stress disorder, traumatic brain injury and eventually even depression.

Study: Cardiac arrest patients often endure debilitating mental fallout

Researchers are beginning to realize that with cardiac arrest patients--many who are treated with device implants such as defibrillators--there are far-greater needs than just performing the surgery. Many of these patients end up facing a wide range of long-term problems including anxiety, post-traumatic stress disorder and depression, according to a new study highlighted by Reuters.

Ecstasy ingredient green-lighted for controversial PTSD study

Keeping an open mind could advance treatment for post-traumatic stress disorder. A pure form of the club drug Ecstasy has emerged as a key component of a controversial and experimental study now enrolling patients with PTSD, which has afflicted thousands of U.S. soldiers after their harrowing experiences in Iraq and Afghanistan, Reuters reports.

Lab aims to pinpoint PTSD with biomarkers

Draper Laboratory, a not-for-profit R&D lab, is seeking funding to find biomarkers to support the diagnosis of post-traumatic stress disorder (PTSD).

Clinical trials to size up antipsychotics like Seroquel for PTSD

The Army is trying to get a better handle on the very complicated issue of how drugs fit into the treatment of the many veterans diagnosed with post-traumatic stress disorder.

Study: Antipsychotic doesn't work for vets' PTSD

New research has so dramatically discredited antipsychotic treatment for post-traumatic stress disorder that experts predict treatment standards will change quickly, the New York Times reports. The

Brain scans accurately ID PTSD

After measuring the magnetic fields in the brain, a research team at the University of Minnesota Medical School and a local VA hospital say they have found a biomarker that can be routinely used to